BCV
HOOK

Banque Cantonale Vaudoise’s HOOKIPA Pharma HOOK Stock Holding History

Banque Cantonale Vaudoise’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,000
Closed -$46K – 1312
2022
Q1 		$46K Buy
+2,000
New +$35.8K ﹤0.01% 1058

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Banque Cantonale Vaudoise's HOOK Position: Q2 2022 in Review

Banque Cantonale Vaudoise sold out of HOOKIPA Pharma (HOOK) in Q2 2022, closing a stake of 2,000 shares — an estimated $46K sold.

Banque Cantonale Vaudoise first reported a position in HOOK in Q1 2022 and held it in 1 quarter. The position peaked at $46K in Q1 2022. 58 funds tracked by Wall St. Rank hold HOOK as of Q2 2022.

  • Banque Cantonale Vaudoise reported no remaining HOOKIPA Pharma position as of Q2 2022 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 2,000 HOOKIPA Pharma shares in Q2 2022, an estimated $46K.
  • Banque Cantonale Vaudoise first reported a position in HOOKIPA Pharma in Q1 2022 and held it in 1 quarter.
  • Banque Cantonale Vaudoise's HOOKIPA Pharma position peaked at $46K in Q1 2022.
  • 58 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2022.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2022, filed 2 Aug 2022.